Butterfly Therapeutics (Previously Lucine) Information
Summary
Butterfly Therapeutics (Previously Lucine) is a private company that has been in the industry for 9 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals, Biotechnology areas. The position of the Founder & CEO is occupied by Maryne Cotty Eslous. Its headquarters is located at Bordeaux, Other, FR. The number of employees ranges from 25 to 100. The annual revenue of Butterfly Therapeutics (Previously Lucine) varies between 1 and 10M. Total funding of the company - $6.5M. To connect with Butterfly Therapeutics (Previously Lucine) employee register on SignalHire.
| Website | butterfly-therapeutics.com |
| Social Links |  |
| Industries | |
| Headquarters address | 106, Avenue Pierre de Coubertin, Laval, Pays de la Loire, 53000 FR |
| Company Size | 10-50 employees |
| Specialties | Pain, Digital therapeutics, Data, AI, Computing vision, Neurosciences, Sociology, TCC, Addiction, Health, Pharmaceutical laboratory, Health Insurance, Hospital |
| Founded | 2017 |
| Estimated Annual Revenue | $1 - 10M |
| Operating Status | Independent Company |
Workforce Turnover
Corporate Tenure Analytics
Workforce Experience Insights
7% have been with the company for 1 to 2 years21% have been with the company for 3 to 4 years29% have been with the company for 5 to 7 years36% have been with the company for 8 to 10 years7% have been with the company for more than 11 years
Similar Companies
FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
